"All Diseases Begin in the Gut"
-Hippocrates
"All Diseases Begin in the Gut"
-Hippocrates
As of today, 3,22,00,49,616 people suffer
from
Functional Gastrointestinal Disorders (FGIDs) globally....
As of today, 3,22,00,49,616 people suffer
from
Functional Gastrointestinal Disorders (FGIDs) globally....
11.2% of Global Population
Irritable Bowel Syndrome is one of the most prevalent FGIDs
7.5% of Indian Population
11.2% of Global Population
Irritable Bowel Syndrome is one of the most prevalent FGIDs
7.5% of Indian Population
SYMPTOMS
SYMPTOMS
EXISTING MEDICATIONS
Serotonin Receptor Inhibitors
Antidepressants
Diarrheal Inhibitors
EXISTING MEDICATIONS
Serotonin Receptor Inhibitors
Antidepressants
Diarrheal Inhibitors
CAUSES
CAUSES
Over the years, increased urbanized lifestyle in India and other drastically developing countries
have caused a drastic change in the dietary patterns of the population leading to the increased
prevalence of Irritable Bowel Syndrome.
Over the years, increased urbanized lifestyle in India and other drastically developing countries have caused a drastic change in the dietary patterns of the population leading to the increased prevalence of Irritable Bowel Syndrome.
Over the years, increased urbanized lifestyle in India and other drastically developing countries have caused a drastic change in the dietary patterns of the population leading to the increased prevalence of Irritable Bowel Syndrome.
Extensive literature survey reveals an increased level of serotonin in the colon of the patients
suffering from IBS-D. But no existing medications target the increased serotonin in the colon, and
come with plenty of side effects, while being expensive and inaccessible.
Extensive literature survey reveals an increased level of serotonin in the colon of the patients suffering from IBS-D. But no existing medications target the increased serotonin in the colon, and come with plenty of side effects, while being expensive and inaccessible.
Extensive literature survey reveals an increased level of serotonin in the colon of the patients suffering from IBS-D. But no existing medications target the increased serotonin in the colon, and come with plenty of side effects, while being expensive and inaccessible.
PRESENTING
PRESENTING
PRESENTING
We introduce ANTHRAFELIX an innovative probiotic based solution to treat the symptoms of IBS-D
We introduce ANTHRAFELIX an innovative probiotic based solution to treat the symptoms of IBS-D
We introduce ANTHRAFELIX an innovative probiotic based solution to treat the symptoms of IBS-D
ANTHRAFELIX harnesses
the power of synthetic biology to create a probiotic that converts excess serotonin in the colon
into melatonin, effectively reducing the severity of the disease.
ANTHRAFELIX harnesses the power of synthetic biology to create a probiotic that converts excess serotonin in the colon into melatonin, effectively reducing the severity of the disease.
ANTHRAFELIX harnesses the power of synthetic biology to create a probiotic that converts excess serotonin in the colon into melatonin, effectively reducing the severity of the disease.
Melatonin is a safe treatment option for IBS as it is an analgesic, has sleep promoting effects and
regulatory effects on the gut.
Melatonin is a safe treatment option for IBS as it is an analgesic, has sleep promoting effects and regulatory effects on the gut.
Melatonin is a safe treatment option for IBS as it is an analgesic, has sleep promoting effects and regulatory effects on the gut.
Genetically modified Probiotics offer several advantages such as stability, specificity, preference,
low cost, and relative safety.
Genetically modified Probiotics offer several advantages such as stability, specificity, preference, low cost, and relative safety.
Genetically modified Probiotics offer several advantages such as stability, specificity, preference, low cost, and relative safety.
